Pharmaceuticals

Malaria Treatment Market Future Outlook Showing Growth Toward $5.73 Billion By 2030

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Malaria Treatment Market Compare Between 2026 And 2030?

The market for malaria treatments has shown significant growth in recent years. This market is forecast to increase from $1.61 billion in 2025 to $1.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.6%. The historical expansion can be attributed to the high prevalence of malaria in tropical regions, the extensive use of chloroquine and artemisinin, global health initiatives such as WHO malaria programs, increased funding for malaria research, and improvements in diagnostic technologies.

The malaria treatment market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $2.18 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This projected increase during the forecast period is driven by factors such as the creation of novel antimalarial vaccines, an increase in drug-resistant malaria strains, the implementation of digital health monitoring systems, the development of healthcare infrastructure across Africa and Asia, and the proliferation of public-private collaborations aimed at malaria elimination. Key developments expected during this period involve the widespread adoption of rapid diagnostic technologies, the broadening of the antimalarial drug development pipeline, the acceleration of vaccine development initiatives, heightened awareness and preventative actions, and the incorporation of telemedicine for managing malaria cases.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11939&type=smp

Which Strong Drivers Are Impacting The Malaria Treatment Market Growth?

The increasing occurrence of malaria is projected to drive the expansion of the malaria treatment market in the foreseeable future. Malaria is defined as a potentially fatal mosquito-borne illness caused by the Plasmodium parasite, manifesting as recurrent fever and other influenza-like symptoms. This escalation in cases is attributed to factors such as poverty, limited availability of healthcare services, climate change, inadequate malaria control measures, and drug resistance. Malaria treatment serves to effectively manage and cure the infection induced by the Plasmodium parasite. For instance, in December 2024, data from the UK Health Security Agency, a government department based in the UK, revealed that imported malaria cases in the UK reached 2,106 in 2023, indicating a 26% rise from 2022. Of these, England reported 1,977 cases, with the remaining distributed across Scotland, Wales, and Northern Ireland. Thus, the high incidence of malaria is fueling the growth of the malaria treatment market. The increase in healthcare spending is anticipated to propel the growth of the malaria treatment market moving forward. Healthcare spending represents the total financial resources allocated to the healthcare sector within a specific geographical area, nation, or organization. Healthcare expenditure on malaria treatment is vital for effectively managing and preventing the spread of the disease, ensuring prompt diagnosis, access to antimalarial medications, and implementation of preventive strategies. For example, in April 2025, according to the Office for National Statistics (ONS), an independent producer of official statistics based in the UK, total healthcare expenditure increased by 6.5% in nominal terms and 2.4% in real terms between 2023 and 2024, while healthcare’s proportion of GDP held steady at 11.1% in 2024. Therefore, augmented healthcare spending is driving the growth of the malaria treatment market.

Which Segment Classifications Are Used In The Malaria Treatment Market Segment Analysis?

The malaria treatment market covered in this report is segmented –

1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments

2) By Route Of Administration: Oral, Parenteral, Intravenous

3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Prescription Medications: Antimalarial Drugs, Prophylactic Medications

2) By Vaccines: RTS,S Or AS01, Other Experimental Vaccines

3) By Diagnostic Tests: Rapid Diagnostic Tests, Microscopy-Based Tests, Polymerase Chain Reaction (PCR) Tests

4) By Other Treatments: Supportive Care, Herbal Remedies, Vector Control Measures

Which Trends Are Contributing To Changes In The Malaria Treatment Market?

Leading companies in the malaria treatment market are concentrating on implementing vaccine programs to strengthen preventative actions and alleviate the global impact of malaria. A vaccine rollout signifies the systematic distribution and administration of vaccines to a populace, typically on a wide scale. For example, in July 2024, Gavi, a Sweden-based vaccine alliance, commenced the R21 malaria vaccine rollout. The R21 vaccine is projected to substantially reduce the occurrence of malaria cases in children under five. This R21 malaria vaccine marks a pivotal achievement in public health initiatives aimed at combating malaria among children, with expectations that it will lead to a distinct decrease in the disease burden and mortality rates linked to this preventable condition.

Which Firms Are Contributing To The Malaria Treatment Market Ecosystem?

Major companies operating in the malaria treatment market are Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Strides Pharma Science Limited, AdvaCare Pharma USA LLC, Actiza Pharmaceutical Private Limited

Get The Full Malaria Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Where Is The Malaria Treatment Market Most Concentrated Geographically?

Middle East and Africa was the largest region in the malaria treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Malaria Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Browse Through More Reports Similar to the Global Malaria Treatment Market 2026, By The Business Research Company

Malaria Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Malaria Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Rare Diseases Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795